Bipolar Disorder
There is a tendency to romanticize bipolar disorder. Many artists,
musicians and writers have suffered from its mood swings. But in truth, many
lives are ruined by this disease; and without effective treatment, the
illness is associated with an increased risk of suicide.
1
Bipolar disorder, also known as manic-depressive illness, is a
serious brain disease that causes extreme shifts in mood, energy, and
functioning. It affects approximately 2.3 million adult Americans—about 1.2
percent of the population.
2 Men and women are equally likely to develop this disabling
illness. The disorder typically emerges in adolescence or early adulthood,
but in some cases appears in
childhood.
3 Cycles, or episodes, of depression, mania, or "mixed" manic
and depressive symptoms typically recur and may become more frequent, often
disrupting work, school, family, and social life.
Depression: Symptoms include a persistent sad mood; loss of
interest or pleasure in activities that were once enjoyed; significant
change in appetite or body weight; difficulty sleeping or oversleeping;
physical slowing or agitation; loss of energy; feelings of worthlessness or
inappropriate guilt; difficulty thinking or concentrating; and recurrent
thoughts of death or suicide.
Mania: Abnormally and persistently elevated (high) mood or
irritability accompanied by at least three of the following symptoms:
overly-inflated self-esteem; decreased need for sleep; increased
talkativeness; racing thoughts; distractibility; increased goal-directed
activity such as shopping; physical agitation; and excessive involvement in
risky behaviors or activities.
"Mixed" state: Symptoms of mania and depression are present at the
same time. The symptom picture frequently includes agitation, trouble
sleeping, significant change in appetite, psychosis, and suicidal thinking.
Depressed mood accompanies manic activation.
Especially early in the course of illness, the episodes may be separated
by periods of wellness during which a person suffers few to no symptoms.
When 4 or more episodes of illness occur within a 12-month period, the
person is said to have bipolar disorder with rapid cycling. Bipolar
disorder is often complicated by co-occurring alcohol or substance abuse.
4
Severe depression or mania may be accompanied by symptoms of psychosis.
These symptoms include: hallucinations (hearing, seeing, or otherwise
sensing the presence of stimuli that are not there) and delusions (false
personal beliefs that are not subject to reason or contradictory evidence
and are not explained by a person's cultural concepts). Psychotic symptoms
associated with bipolar typically reflect the extreme mood state at the
time.
Treatments
A variety of medications are used to treat bipolar disorder.
5 But even with optimal medication treatment, many people with the
illness have some residual symptoms. Certain types of psychotherapy or
psychosocial interventions, in combination with medication, often can
provide additional benefit. These include cognitive-behavioral therapy,
interpersonal and social rhythm therapy, family therapy, and psychoeducation.
6,7
Lithium has long been used as a first-line treatment for bipolar
disorder. Approved for the treatment of acute mania in 1970 by the U.S. Food
and Drug Administration (FDA), lithium has been an effective
mood-stabilizing medication for many people with bipolar disorder.
Anticonvulsant medications, particularly valproate and carbamazepine,
have been used as alternatives to lithium in many cases. Valproate was FDA
approved for the treatment of acute mania in 1995. Newer anticonvulsant
medications, including lamotrigine, gabapentin, and topiramate, are being
studied to determine their efficacy as mood stabilizers in bipolar disorder.
Some research suggests that different combinations of lithium and
anticonvulsants may be helpful.
According to studies conducted in Finland in patients with epilepsy,
valproate may increase testosterone levels in teenage girls and produce
polycystic ovary syndrome in women who began taking the medication before
age 20.
8 Increased testosterone can lead to polycystic ovary syndrome
with irregular or absent menses, obesity, and abnormal growth of hair.
Therefore, young female patients taking valproate should be monitored
carefully by a physician.
During a depressive episode, people with bipolar disorder commonly
require additional treatment with antidepressant medication. Typically,
lithium or anticonvulsant mood stabilizers are prescribed along with an
antidepressant to protect against a switch into mania or rapid cycling. The
comparative efficacy of various antidepressants in bipolar disorder is
currently being studied.
In some cases, the newer, atypical antipsychotic drugs such as
clozapine or olanzapine may help relieve severe or refractory symptoms of
bipolar disorder and prevent recurrences of mania. More research is needed
to establish the safety and efficacy of atypical antipsychotics as long-term
treatments for this disorder.
Research Findings
More than two-thirds of people with bipolar disorder have at least one
close relative with the disorder or with unipolar major depression,
indicating that the disease has a heritable component.
9 Studies seeking to identify the
genetic basis of bipolar disorder indicate that susceptibility stems
from multiple genes. Scientists are continuing their search for these genes
using advanced genetic analytic methods and large samples of families
affected by the illness. The researchers are hopeful that identification of
susceptibility genes for bipolar disorder, and the brain proteins they code
for, will make it possible to develop better treatments and preventive
interventions targeted at the underlying illness process.
Researchers are using advanced imaging techniques to examine brain
function and structure in people with bipolar disorder.
10,11
An important area of imaging research focuses on identifying and
characterizing networks of interconnected nerve cells in the brain,
interactions among which form the basis for normal and abnormal behaviors.
Researchers hypothesize that abnormalities in the structure and/or function
of certain brain circuits could underlie bipolar and other mood disorders.
Better understanding of the neural circuits involved in regulating mood
states will influence the development of new and better treatments, and will
ultimately aid in diagnosis.
New Clinical Trial
NIMH has initiated a large-scale study at 20 sites across the U.S. to
determine the most effective treatment strategies for people with bipolar
disorder. This study, the Systematic Treatment Enhancement Program for
Bipolar Disorder (STEP-BD), will follow patients and document their
treatment outcome for 5 to 8 years. For more information, visit the
Clinical Trials page of the NIMH Web site.
For More Information
National Institute of
Mental Health (NIMH)
Office of Communications and Public Liaison
Public Inquiries: (301) 443-4513
Media Inquiries: (301) 443-4536
E-mail:
http://www.nimh.nih.gov/publicat/mailto:nimhinfo@nih.gov
Web site:
http://www.nimh.nih.gov/
-----------------------------------
All material in this fact sheet is in the public domain and may be
copied or reproduced without permission from the Institute. Citation of the
source is appreciated.
NIH Publication No. 01-4595
-----------------------------------
References
1 Brown GK, Beck AT, Steer RA, et al. Risk factors
for suicide in psychiatric outpatients: a 20-year prospective study.
Journal of Consulting and Clinical Psychology, 2000; 68(3): 371-7.
2 Narrow WE. One-year prevalence of depressive
disorders among adults 18 and over in the U.S.: NIMH ECA prospective data.
Population estimates based on U.S. Census estimated residential population
age 18 and over on July 1, 1998. Unpublished.
3 Geller B, Luby J. Child and adolescent bipolar
disorder: a review of the past 10 years. Journal of the American Academy
of Child and Adolescent Psychiatry, 1997; 36(9): 1168-76.
4 Robins LN, Regier DA, eds. Psychiatric
disorders in America: the Epidemiologic Catchment Area Study. New York:
The Free Press, 1991.
5 Sachs GS, Printz DJ, Kahn DA, et al. The expert
consensus guideline series: medication treatment of bipolar disorder 2000.
Postgraduate Medicine, 2000; Spec No: 1-104.
6 American Psychiatric Association. Practice
guideline for the treatment of patients with bipolar disorder. American
Journal of Psychiatry, 1994; 151(12 Suppl): 1-36.
7 Frank E, Hlastala S, Ritenour A, et al. Inducing
lifestyle regularity in recovering bipolar disorder patients: results from
the maintenance therapies in bipolar disorder protocol. Biological
Psychiatry, 1997; 41(12): 1165-73.
8 Vainionpaa LK, Rattya J, Knip M, et al.
Valproate-induced hyperandrogenism during pubertal maturation in girls with
epilepsy. Annals of Neurology, 1999; 45(4): 444-50.
9 NIMH Genetics Workgroup. Genetics and mental
disorders. NIH Publication No. 98-4268. Rockville, MD: National
Institute of Mental Health, 1998.
10 Soares JC, Mann JJ. The anatomy of mood
disorders-review of structural neuroimaging studies. Biological
Psychiatry, 1997; 41(1): 86-106.
11 Soares JC, Mann JJ. The functional
neuroanatomy of mood disorders. Journal of Psychiatric Research,
1997; 31(4): 393-432. |